Interim position statement: Tocilizumab for patients admitted to ICU with COVID-19 pneumonia (adults)
A UK-wide position statement has been agreed to support off-label prescribing and access to tocilizumab.
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
No comments yet.